Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas ; volume:15 ; number:1 ; day:19 ; month:5 ; year:2023 ; pages:1-33 ; date:12.2023
Clinical epigenetics ; 15, Heft 1 (19.5.2023), 1-33, 12.2023

Creator: Tang, Zijiao
Liu, Lu
Borlak, Jürgen

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13148-023-01500-1

URN: urn:nbn:de:101:1-2023090911465378017051

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:44 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Tang, Zijiao
Liu, Lu
Borlak, Jürgen
SpringerLink (Online service)

Other Objects (12)

Hochschulschrift

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Hochschulschrift

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Hochschulschrift

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Improved potency of decitabine in human colorectal cancer and colorectal liver metastasis cell lines, [Band].

Correction to: Decitabine/Cedazuridine: First Approval

Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study

Epigenetic synergy between decitabine and platinum derivatives

Adenosine deaminase deficiency: a review

Earthquake fatalities and potency

Potency in soluble groups

Urogenital Abnormalities in Adenosine Deaminase Deficiency

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Genomics and epidemiology for gastric adenocarcinomas

Finding the potency in planarians

Related objects

Reset password